Navigation Links
Single bioptic telescope for low vision driving may not obscure road view of second eye
Date:5/9/2011

Boston, MAA study by scientists at Schepens Eye Research Institute shows that a bioptic telescope on one lens of a pair of glasses used to magnify traffic signs and lights may not prevent the wider view of the road with the second eye. The study results, which will be published in the May 2011 Archives of Ophthalmology, are the first evidence that--under more realistic viewing conditions than in earlier studies--the second eye can detect objects in the area obscured by the magnification effect of the telescope (called the ring scotoma).

"These study results are significant because they should ease official and public concerns about the safety of bioptic telescope use for driving with visual impairments," says Dr. Eli Peli, the principal investigator of the study, who is a low vision expert, a senior Schepens scientist, and a professor of Ophthalmology at Harvard Medical School.

In previous studies, participants wearing the bioptic telescope were asked to view a blank (plain) background and focus on a simple fixation pointa cross while detecting random visual targets presented to them, a task that requires little attention and concentration.

"Our current study required subjects to view more complex, textured backgrounds and focus on and read letters, which are more akin to visual situations encountered in real life and on the road," says Peli.

Bioptics, developed more than 100 years ago, are small telescopes that are attached above the center of one spectacle lens. A slight downward tilt of the head and upward shift of the eyes can bring a distant road sign or traffic light into view for people with vision impairments. When looking through the telescope, a blind area (scotoma) is created due to the magnification of the telescope. The blind area is in the shape of a ring surrounding what is seen through the telescope (hence the name "ring scotoma"). For instance, a person viewing a traffic light with the telescope will see the light, but will not be able to see the surrounding intersection, with the same eye. Although bioptics were introduced as driving aids 50 years ago and are approved for driving in 39 states, safety has remained a concern, in particular the effect of the ring scotoma on detection of traffic hazards. In some states this concern resulted in restricting the telescope to one eye only, leaving the other to monitor the area of the ring scotoma during telescope use.

In the Archives of Ophthalmology study, Amy Doherty, the first author, and the research team, conducted a series of tests evaluating the ability of the second (fellow) eye to detect targets in the area of the ring scotoma on both simple and complex backgrounds, with and without the bioptic telescope on one lens.

They began by fitting 14 subjects with bioptic glasses and used a novel display system that allowed them to present visual stimuli to each eye separately while both eyes were watching the screen. The team then "mapped" or determined the dimensions and position of the blind area (ring scotoma) in each subject's telescopic eye by presenting visual stimuli only to that eye.

Next, each subject underwent four viewing conditions while wearing the telescope in front of one eye, and the same four conditions without the telescope. In all cases, both eyes were open, while a visual stimulus or target (a small checkerboard square), presented to the second eye only, appeared randomly in different parts of the ring scotoma area. The subjects pressed a button whenever they saw the target.

The four conditions were: passively viewing a cross on a gray background, passively viewing a cross on a more complex textured background, actively reading letters on a gray background, and actively reading letters on the textured background. The textured background seen magnified in the telescopic eye resulted in a rivalry (competition) effect between the images from the two eyes that could result in the brain ignoring (suppressing) the image from the second eye. Any suppression of the second eye when looking through a bioptic telescope could potentially result in a traffic hazard not being noticed.

In all cases no significant difference was found between what the second eye saw when the first eye was using the telescope and when it wasn't using the telescope. With the bioptics, the second eye was able to detect the target 86 percent of the time, while without the bioptics, it detected the target 87 percent of the time. As expected, more targets were detected on a gray background than on a textured background and while focused on a simple cross than while reading letters.

"These results suggest that the bioptic driver may not be blind to traffic when looking through the telescope, because the second eye can detect targets in the area obscured by the telescope," says Doherty.

While the study results are encouraging, Peli and Doherty agree that it is still essential to test the use of bioptics in even more realistic circumstances.

"Our next testing conditions will be with video segments that closely mimic the visual scene and attention required during actual driving situations," says Doherty, who adds that over time, the research team also hopes to gather data from driving simulators and even actual on-the-road monitoring.


'/>"/>

Contact: Patti Jacobs
pjacobs12@comcast.net
617-864-2712
Schepens Eye Research Institute
Source:Eurekalert

Related medicine news :

1. Single Gene Linked to Evolution of Human Brain
2. Advanced technology reveals activity of single neurons during seizures
3. Single gene defect causes brain tumor
4. See how they grow: Monitoring single bacteria without a microscope
5. Cancer in a single catastrophe
6. Scientists Aim for Test That Spots Single Cancer Cell in Blood Sample
7. Scientists Aim for Test That Could Spot Single Cancer Cell in Blood
8. Single Embryo Beat Double Embryo Transfer in IVF Study
9. New combo lung cancer therapy improves survival over single-line treatment
10. Lesbian, gay and bisexual teens singled out for punishment
11. Mutations in single gene predict poor outcomes in adult leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... Universal Medical Systems, ... and the first company to offer robotic imaging to veterinary medicine is sponsoring ... # 941 for the American Association of Equine Practitioners 62nd Annual Convention from ...
(Date:12/2/2016)... ... , ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique wearable technology ... health technology on the market can deliver all that rejiva can. , “Rejiva promotes ... their health than the usual heart rate and steps taken”, adds Evens Augustin, CEO ...
(Date:12/2/2016)... Viejo, California (PRWEB) , ... December 02, 2016 , ... ... will allow FCPX editors to create versatile lower third titles with just a few ... , Pro3rd Accents Volume 2 includes 30 lower third animations. Choose from various styles ...
(Date:12/2/2016)... ... 02, 2016 , ... On November 24th, 2016, Thanksgiving morning, ... different sites throughout Miami-Dade and Broward counties. This is the largest meal delivery ... Thanksgiving morning by putting together individual meals via assembly lines and passing them ...
(Date:12/2/2016)... ... December 02, 2016 , ... Date aired: November ... Type 2 Diabetes: The Owner’s Manual, http://realtimepressrelease.com/press-releases-tagged-with/daryl-wein , Sharon Kleyne, ... Water, Global Climate Change and Your Health radio program syndicated on Voice of ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... , December 2, 2016 ... Vitro Diagnostics/IVD Market by Product (Instruments, Reagents, Software), ... (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) - Forecast ... is valued at USD 60.22 Billion in 2016. ... CAGR of 5.5% during the forecast period (2016-2021) ...
(Date:12/2/2016)...  PipelineRx, a leading medication management technology company ... of its SaaS-based telepharmacy platform, PowerGridRx™ , ... Midyear Clinical Meeting and Exhibition, December 5-7 in ... 300 hospital clients nationally, the Company is a ... dramatically improve pharmacy operations, enhance patient safety, and ...
(Date:12/2/2016)... -- On Thursday, December 1st 2016, the ... development and innovation in the biopharmaceutical industry at its ... the presence of Sergey Tsyb, Vice Minister of Industry ... , Natalia Sanina, First Vice Chairman of the State ... Roszdravnadzor, National Service of Control in Healthcare, Sergey Muravev, ...
Breaking Medicine Technology: